QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

ANRO

QT70Alto Neuroscience, Inc.
NYSE·Healthcare·Biotechnology·USA
Latest market price
22.74
+0.95+4.36%
OverviewShort InterestFilings
ANROQT70Alto Neuroscience, Inc.·NYSE
OverviewShort InterestFilings
22.74+4.36%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own5.36%
Shs Outstand35.09M
Perf Week6.11%
Market Cap764.70MForward P/E-EPS next Y-3.23Insider Trans0.00%Shs Float-Perf Month11.20%
Enterprise Value506.63MPEG1.30EPS next Q-0.71Inst Own-Short Float-Perf Quarter3.18%
Income-79299074.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y32.98%
Sales-P/B2.95EPS next Y-7.64%ROA-26.90%Short Interest-Perf YTD27.75%
Book/sh6.92P/C-EPS next 5Y-ROE-47.22%52W High28.44 -20.04%Perf Year919.73%
Cash/sh7.52P/FCF-EPS past 3/5Y-ROIC20.70%52W Low2.15 957.67%Perf 3Y-
Dividend Est.-EV/EBITDA-7.11Sales past 3/5Y-Gross Margin0.00%Volatility4.71% 4.72%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM3.20%Oper. Margin0.00%ATR (14)1.61Perf 10Y-
Dividend Ex-Date-Quick Ratio20.52Sales Y/Y TTM-Profit Margin0.00%RSI (14)57.00Recom2.33
Dividend Gr. 3/5Y-Current Ratio20.52EPS Q/Q-50.94%SMA2011.23%Beta2.49Target Price34.60
Payout0.00%Debt/Eq0.02Sales Q/Q-SMA50-0.60%Rel Volume1.68Prev Close21.79
Employees76LT Debt/Eq0.03EarningsAug 12SMA20039.17%Avg Volume333.17KPrice22.74
IPO DateFeb 02, 2024Option/ShortYes / YesEPS/Sales Surpr.-42.86% -Net Debt/EBITDA3.62Volume558,218Change4.36%
Analyst Ratings
DateActionAnalystRatingTarget
May-27-26ReiteratedH.C. Wainwright$50
May-18-26ReiteratedRobert W. Baird$38 → $36
May-14-26ReiteratedWedbushNeutral$24
Mar-16-26ReiteratedJefferiesBuy$35
Feb-17-26ReiteratedBTIGBuy$28
Oct-20-25ReiteratedRobert W. Baird$10 → $16
Oct-23-24ReiteratedRobert W. Baird$32 → $10
Oct-23-24DowngradeWedbushOutperform → Neutral
Jun-20-24ReiteratedRobert W. Baird$32
Latest News
Jun-15-26
Jun-15-2612:03PM
Alto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on AnhedoniaYahoo
08:11AM
Alto Neuroscience Publishes Trial Of Dopamine Agonist Pramipexole With Mood Disorders And Clinically Significant Anhedonia In Nature MediceBenzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
Total Revenue
000
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A110
Gross Profit-1-10
Selling, General and Administrative Excl. Other21228
Research and Development464730
Other Operating Expense-1-10
Operating Income-66-69-38
Interest Expense2-11
Unusual Expense
———
Non-Operating Income (Expense)-6-6-3
Net Income Before Taxes-63-61-36
Income Taxes
000
Consolidated Net Income-63-61-36
Net Income From Continuing Operations-63-61-36
Net Income-63-61-36
EPS (Recurring)-2.19-2.50-1.35
EPS (Basic, Before Extraordinaries)-2.19-2.50-1.35
EPS (Diluted)-2.19-2.50-1.35
EBITDA-60-62-35
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding292527
Market Capitalization516——
Operating Lease Expense
———
Insider Trading Volume
$23.82$21.59$19.37$17.15$14.92● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Savitz AdamCHIEF MEDICAL OFFICERJul 10 '24Buy13.222,93138,74839,851Jul 11 12:00 AM
Savitz AdamCHIEF MEDICAL OFFICERJul 09 '24Buy12.6012,069152,08536,920Jul 11 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR